awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33766568-02D265E8-31AC-43D4-831A-F412301D03DA
Q33766568-02D265E8-31AC-43D4-831A-F412301D03DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33766568-02D265E8-31AC-43D4-831A-F412301D03DA
High drug-loading nanomedicines: progress, current status, and prospects.
P2860
Q33766568-02D265E8-31AC-43D4-831A-F412301D03DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33766568-02D265E8-31AC-43D4-831A-F412301D03DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
032ed7bbf1d4f2c35f8a9e46993e0aec27a4ed69
P2860
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.